CompuGroup Medical (0MSD) AI Stock Analysis

CompuGroup Medical

(LSE:0MSD)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Recurring SaaS and diversified revenue streamsA mixed model of one‑time license sales plus subscription and cloud SaaS creates recurring revenue and higher customer lifetime value. This durability improves predictability, supports retention and upsell, and underpins multi‑year cash flow visibility for reinvestment and debt servicing.

Negative Factors

Moderate leverage and reliance on debt financingA moderate debt load reduces financial flexibility and raises sensitivity to interest costs and refinancing cycles. Over a multi‑month horizon this can constrain strategic moves, limit opportunistic M&A, and force prioritization of cash to debt service rather than growth or shareholder distributions.

CompuGroup Medical (0MSD) vs. iShares MSCI United Kingdom ETF (EWC)

Market Cap: EUR 803.80M
Dividend Yield: 1.77%
Average Volume (3M): 673
Price to Earnings (P/E): 43.4
Beta (1Y): 0.02
Revenue Growth: ―
EPS Growth: ―
Country: UK
Employees: 8,299
Sector: General
Sector Strength: 55
Industry: Medical - Healthcare Information Services

CompuGroup Medical Business Overview & Revenue Model

Company Description

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide. It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital In...

CompuGroup Medical Peers Comparison

Overall Rating

UnderperformOutperform

Sector (55)

Financial Indicators

GB:0MSD against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
DE:AFX	73Outperform	EUR 3.13B	20.86	5.52%	1.58%	-0.06%	-38.81%
DE:AJ91	72Outperform	EUR 53.28M	11.41	11.67%	9.52%	1.35%	-20.52%
DE:M3V	68Neutral	EUR 37.13M	26.58	7.77%	4.70%	-6.92%	-67.82%
DE:BC8	60Neutral	EUR 4.22B	17.44	12.00%	2.05%	7.74%	14.82%
DE:ADN1	59Neutral	EUR 474.60M	26.34	9.65%	1.04%	12.73%	51.34%
Sector *	55Neutral	$6.65B	3.83	-15.92%	6.20%	10.91%	7.18%

* General Sector Average

Performance Comparison

GB:0MSD and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
GB:0MSD	CompuGroup Medical	28.30	4.25	17.69%
DE:ADN1	adesso AG	74.80	-15.42	-17.09%
DE:BC8	Bechtle Aktiengesellschaft	34.18	-0.29	-0.85%
DE:AFX	Carl Zeiss Meditec	34.84	-7.12	-16.96%
DE:M3V	MeVis Medical Solutions	20.20	-4.09	-16.82%
DE:AJ91	DocCheck AG	10.50	-0.80	-7.10%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

CompuGroup Medical AI Stock Analysis